Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 3.8/5
3SBio Inc (1530 HK)
Watchlist
Contact IR
125
Analysis
Health Care
•
China
3SBio, Inc. is a biotechnology company located in China. The Company focuses on mammalian cell-based biopharmaceuticals in the biotechnology industry. 3SBio also develops, manufactures and markets biopharmaceutical products globally.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
3SBio Inc
•
21 Jul 2025 23:18
3SBio (1530 HK): Global Index Inclusion as Stock Soars
3SBio could be added to a global index in August. There is large positioning in the stock, but industry momentum could lead to further upside in...
Brian Freitas
Follow
458 Views
Share
bullish
•
3SBio Inc
•
01 Jul 2025 00:30
3SBio Inc (1530 HK): Licensing Deal a Market Hit; Will It Continue?
3SBio signed $6B outlicensing deal with Pfizer for SSGJ-707, resulting in spectacular rally in 3SBio shares. Global trial initiation of SSGJ-707...
Tina Banerjee
Follow
189 Views
Share
bullish
•
Thematic (Sector/Industry)
•
28 Jul 2025 00:53
What Happens to China Healthcare? - The Soaring Shares, the Turning Point, and the Top Picks
Hengrui has entered into agreements with GSK for HRS-9821 and up to 11 programs, with high upfront payment of US$500 million and total amount of...
Xinyao (Criss) Wang
Follow
409 Views
Share
bullish
•
3SBio Inc
•
27 Mar 2025 11:51
•
Broker
3SBio (1530 HK) - Earnings Beat, Rich Pipeline Promises Future Growth
3SBio delivered a strong performance in 2024. Revenue increased 16.5% YoY to RMB9.1bn, exceeding our estimates by 3.3%, driven by the continued...
CMB International
Follow
216 Views
Share
bearish
•
Quantitative Analysis
•
27 Jul 2025 02:10
HK Short Interest Weekly: Kuaishou, Cspc Pharma, Galaxy Ent, ABC
We analyzed the latest HK SFC report for aggregate short position as of Jul 18th and highlight short interest changes in Kuaishou, Cspc Pharma,...
Ke Yan, CFA, FRM
Follow
296 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.55.4
x